The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age-Reference-Cited by-同舟云学术

The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age

Published:2022-05-23 Issue:3 Volume:158 Page:405-412
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Vuong Huy Gia,Ngo Tam N. M.,Le Hieu Trong,Dunn Ian F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-04027-2.pdf

Reference49 articles.

1. Louis DN et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135(4):639–642

2. Hake SB, Allis CD (2006) Histone H3 variants and their potential role in indexing mammalian genomes: the “H3 barcode hypothesis.” Proc Natl Acad Sci 103(17):6428

3. Schulte JD et al (2020) Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv 2(1):vdaa142

4. Schreck KC et al (2019) Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol 143(1):87–93

5. Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9(2):197–206

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management;Cancer Letters;2024-10

2. Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis;International Journal of Molecular Sciences;2024-09-07

3. Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort;Acta Neuropathologica Communications;2024-07-27

4. The immune response behind peptide vaccination in diffuse midline glioma;Molecular Oncology;2024-06-16

5. ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma;Journal of Clinical Oncology;2024-05-01